TW202128125A - External preparation for skin - Google Patents

External preparation for skin Download PDF

Info

Publication number
TW202128125A
TW202128125A TW109135638A TW109135638A TW202128125A TW 202128125 A TW202128125 A TW 202128125A TW 109135638 A TW109135638 A TW 109135638A TW 109135638 A TW109135638 A TW 109135638A TW 202128125 A TW202128125 A TW 202128125A
Authority
TW
Taiwan
Prior art keywords
skin
component
external preparation
water
external
Prior art date
Application number
TW109135638A
Other languages
Chinese (zh)
Inventor
須藤充人
Original Assignee
日商高絲股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商高絲股份有限公司 filed Critical 日商高絲股份有限公司
Publication of TW202128125A publication Critical patent/TW202128125A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/10Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12Face or body powders for grooming, adorning or absorbing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • A61K2800/542Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5424Polymers characterized by specific structures/properties characterized by the charge anionic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The present invention addresses the problem of obtaining a composition that contains niacinamide and is not sticky, provides an excellent feeling of penetration, and also gives an excellent feeling of firmness after use. The external preparation for skin that solves this problem is an external preparation for skin that contains the following components (A)-(D): (A) 1-10 mass% niacinamide, (B) a cationic surfactant, (C) an anionic polymer, and (D) water.

Description

皮膚外用劑Skin topical agent

本發明係有關於一種含有菸鹼醯胺的皮膚外用劑,更詳而言之,係有關於一種含有陽離子性界面活性劑與陰離子性高分子,穩定性亦優良的皮膚外用劑。The present invention relates to an external preparation for skin containing nicotine amide, and more specifically, it relates to an external preparation for skin containing a cationic surfactant and an anionic polymer with excellent stability.

皮膚會因年齡增長或壓力等內在因素,或者紫外線或空氣乾燥等外在因素而產生斑點、皺紋、鬆弛或色素沉著等。其中,由於皺紋、鬆弛等形態變化極影響外觀印象,而期望改善者眾。為了預防、改善此等皺紋、鬆弛,有人提出多種有效成分;其中,已知菸鹼醯胺的安全性高,且具有抗皮膚老化效果(例如參照專利文獻1、2)。然而,含有大量菸鹼醯胺時,已知黏膩感較強等有不理想的使用觸感,而有人已加以改善(例如參照專利文獻3)。Skin can cause spots, wrinkles, sagging or pigmentation due to internal factors such as aging or stress, or external factors such as ultraviolet rays or dry air. Among them, morphological changes such as wrinkles and sagging greatly affect the appearance impression, and many people expect improvement. In order to prevent and improve such wrinkles and sagging, various active ingredients have been proposed; among them, nicotine amide is known to be highly safe and has anti-aging effects on the skin (for example, refer to Patent Documents 1 and 2). However, when a large amount of nicotine amide is contained, it is known that there is an undesirable feeling in use, such as a strong stickiness, and some people have improved it (for example, refer to Patent Document 3).

另外,對於局部塗佈於皮膚及毛髮而使用的化妝料或皮膚外用劑,有人致力研發提升有效成分對組織內部的滲透性。作為其手段之一,可舉出利用組成物中的電荷。咸認皮膚表面帶有負電荷,而帶有正電荷的陽離子性物質,已知對皮膚的吸附性或滲透性較高。因此,為了提高有效成分對生物體組織的吸附性及滲透性,有人提供含有陽離子化聚合物的化妝料(例如參照專利文獻4、5)。然而,併用陰離子性物質時,由於在組成物中會形成複合物,而有發生白濁,或者產生凝聚物或結塊等問題。又,作為供提升有效成分的滲透性的其他手段,可舉出利用囊泡粒子,亦已知有組合此2種手段之含有陽離子性界面活性劑的囊泡組成物(例如參照專利文獻6)。 [先前技術文獻] [專利文獻]In addition, for cosmetics or external skin preparations used for topical application to the skin and hair, some people have devoted themselves to research and development to improve the penetration of active ingredients into tissues. As one of the means, the use of electric charges in the composition can be mentioned. Salty recognizes that the surface of the skin is negatively charged, and positively charged cationic substances are known to have higher absorption or permeability to the skin. Therefore, in order to improve the adsorption and permeability of the active ingredients to the biological tissues, cosmetics containing cationized polymers have been provided (for example, refer to Patent Documents 4 and 5). However, when an anionic substance is used in combination, since a complex is formed in the composition, there are problems such as cloudiness, aggregation or agglomeration. In addition, as another means for enhancing the permeability of the active ingredient, the use of vesicle particles can be cited, and a vesicle composition containing a cationic surfactant combining these two means is also known (for example, refer to Patent Document 6) . [Prior Technical Literature] [Patent Literature]

[專利文獻1]日本特開平10-130135號公報 [專利文獻2]日本特開平10-001414號公報 [專利文獻3]日本特表2003-502435號公報 [專利文獻4]日本特開2016-108344號公報 [專利文獻5]國際公開2019/111415號手冊 [專利文獻6]國際公開2014/069631號手冊[Patent Document 1] Japanese Patent Laid-Open No. 10-130135 [Patent Document 2] Japanese Patent Laid-Open No. 10-001414 [Patent Document 3] Japanese Special Publication No. 2003-502435 [Patent Document 4] JP 2016-108344 A [Patent Document 5] International Publication No. 2019/111415 Handbook [Patent Document 6] International Publication No. 2014/069631 Handbook

[發明所欲解決之課題][The problem to be solved by the invention]

從而,於本發明中,係以開發出一種雖含有皮膚滲透性優良的陽離子性界面活性劑,但可抑制、緩和電性交互作用所產生的凝聚物等而穩定性良好,且可與各種陰離子性物質併用之技術為課題。又,本發明係以提供一種大量摻混作為有效成分之菸鹼醯胺,使用時亦無黏膩感,對肌膚的滲透性優良,且塗敷後肌膚之緊緻感等的完妝真實感亦優異的皮膚外用劑為目的。 [解決課題之手段]Therefore, in the present invention, a cationic surfactant with excellent skin permeability has been developed, but it can inhibit and alleviate the agglomerates generated by the electrical interaction and has good stability, and can interact with various anions. The technology of combined use of sexual substances is the subject. In addition, the present invention is to provide a large amount of nicotine amide blended as an effective ingredient, which does not have a sticky feeling when used, has excellent permeability to the skin, and has a firmness and firmness of the skin after application. It is also an excellent external preparation for the skin. [Means to solve the problem]

因此,本案發明人為解決上述課題而致力累積多次研究的結果發現,在含有陽離子性界面活性劑及陰離子性高分子的組成物中,透過共同使用菸鹼醯胺,可緩和陽離子性界面活性劑與陰離子性高分子之電性交互作用所引起的凝聚,而完成本發明。Therefore, the inventors of the present case have worked hard to solve the above-mentioned problems. As a result, they have found that in a composition containing a cationic surfactant and an anionic polymer, the use of nicotine amide can alleviate the cationic surfactant. Condensation caused by electrical interaction with anionic polymers completes the present invention.

亦即,本發明係提供一種皮膚外用劑,其係含有下列成分(A)~(D): (A)菸鹼醯胺1~10質量%、 (B)陽離子性界面活性劑、 (C)陰離子性高分子、 (D)水。 [發明之效果]That is, the present invention provides an external preparation for skin, which contains the following components (A) to (D): (A) Nicotinamide 1-10% by mass, (B) Cationic surfactant, (C) Anionic polymer, (D) Water. [Effects of Invention]

根據本發明,透過共同使用菸鹼醯胺,可抑制陽離子性界面活性劑與陰離子性高分子之電性交互作用所致之沉澱物的產生。又,本發明之皮膚外用劑,使用時無黏膩感,對肌膚的滲透感優良,且塗敷後肌膚之緊緻感等的完妝效果感優異。此外,該皮膚外用劑由於穩定性優良,可長時間使用,藉此,而有用於作為可提升肌膚的彈力,可預防或改善皺紋、肌膚鬆弛等老化形態變化之抗老化效果可期的化妝料。According to the present invention, by using nicotine amide together, the generation of precipitates caused by the electrical interaction between the cationic surfactant and the anionic polymer can be suppressed. In addition, the external preparation for skin of the present invention has no sticky feeling when used, has excellent penetration into the skin, and has excellent makeup effects such as firmness of the skin after application. In addition, the external preparation for skin can be used for a long time due to its excellent stability. Therefore, it can be used as a cosmetic that can improve skin elasticity, prevent or improve wrinkles, sagging skin, and other aging morphological changes. .

[實施發明之形態][The form of implementing the invention]

以下就本發明詳細加以說明。此外,本說明書中,「~」係指包含其前後之數值的範圍。 本發明所使用之成分(A)菸鹼醯胺為菸鹼酸(維生素B3/菸酸)的醯胺化合物。菸鹼醯胺為水溶性維生素,係屬維生素B群之一的週知物質,可由天然物(米糠等)萃取而出,或者藉由週知方法來合成。具體而言,可使用第17次修訂日本藥典所記載者。The present invention will be described in detail below. In addition, in this specification, "~" refers to the range including the numerical value before and after it. The component (A) nicotine amide used in the present invention is a niacin compound of nicotinic acid (vitamin B3/nicotinic acid). Nicotinamide is a water-soluble vitamin. It is a well-known substance belonging to the vitamin B group. It can be extracted from natural products (rice bran, etc.) or synthesized by well-known methods. Specifically, those described in the 17th revised Japanese Pharmacopoeia can be used.

本發明中之成分(A)的含量為1~10質量%(以下,將「質量%」簡稱為「%」),較佳為3~10%,特佳為4~9%。成分(A)的含量若未達1%,無法獲得緊緻感等;而超過10%時,則塗佈時的黏膩感較強,使用感較差。The content of the component (A) in the present invention is 1-10% by mass (hereinafter, "mass%" is abbreviated as "%"), preferably 3-10%, particularly preferably 4-9%. If the content of component (A) is less than 1%, firmness and the like cannot be obtained; and when it exceeds 10%, the stickiness during application is stronger and the feeling in use is poor.

本發明所使用之成分(B)陽離子性界面活性劑係供提升對肌膚的吸附性,以及作為皮膚外用劑之滲透感與肌膚親和性等者,只要是在一般的化妝料或皮膚外用劑等中使用者則不特別限制,可使用任意者。 成分(B)為烷基胺鹽、多胺及胺醇脂肪酸衍生物等胺鹽、烷基四級銨鹽、芳香族四級銨鹽、吡啶鎓鹽、咪唑鎓鹽等,可舉出例如氯化十六基三甲銨、溴化十六基三甲銨、氯化十八基三甲銨、溴化十八基三甲銨、氯化二十二基三甲銨、溴化二十二基三甲銨、甲基硫酸二十二基三甲銨、氯化二(十八基)二甲銨、溴化二油基二甲銨、甲基硫酸十六基二十二基二甲銨、氯化十八基二甲基苯甲銨、二棕櫚醯乙基羥乙基甲基銨甲基硫酸鹽、二椰油醯乙基羥乙基甲基銨甲基硫酸鹽、二硬脂醯乙基羥乙基甲基銨甲基硫酸鹽等四級銨鹽,可由此等當中選擇1種或2種以上。The component (B) cationic surfactant used in the present invention is used to enhance the absorption to the skin, as well as the penetration and skin affinity as an external agent for skin, as long as it is used in general cosmetics or external skin agents, etc. The middle user is not particularly limited, and any one can be used. Component (B) is amine salts such as alkyl amine salts, polyamines and amino alcohol fatty acid derivatives, alkyl quaternary ammonium salts, aromatic quaternary ammonium salts, pyridinium salts, imidazolium salts, etc., for example, chlorine Cetyl trimethyl ammonium bromide, cetyl trimethyl ammonium bromide, octadecyl trimethyl ammonium chloride, octadecyl trimethyl ammonium bromide, behenyl trimethyl ammonium chloride, behenyl trimethyl ammonium bromide, methyl Behenyl trimethyl ammonium sulfate, di(octadecyl) dimethyl ammonium chloride, dioleyl dimethyl ammonium bromide, hexadecyl behenyl dimethyl ammonium methyl sulfate, octadecyl two chloride Methylbenzylammonium, dipalmitin ethyl hydroxyethyl methyl ammonium methyl sulfate, dicoconut oil ethyl hydroxyethyl methyl ammonium methyl sulfate, distearyl ethyl hydroxyethyl methyl sulfate Quaternary ammonium salts such as ammonium methyl sulfate can be selected from one or two or more of these.

此外,就本發明之成分(B),只要是在組成物中具有陽離子性者,則亦可為兩性界面活性劑之骨架。作為此種界面活性劑,較佳為具有胺基酸殘基者,較佳的是該胺基酸殘基為鹼性胺基酸殘基。具體而言,可例示硬脂醯基離胺酸丁基酯・鹽酸鹽、N-椰油醯基-L-精胺酸乙基酯吡咯啶酮羧酸鹽、月桂醯基-鳥胺酸丙基酯・酢酸鹽等單-N-長鏈醯基鹼性胺基酸低級烷基酯鹽;癸基胍酢酸鹽、2-胍基乙基月桂基醯胺鹽酸鹽、2-胍基丁基硬脂醯胺・DL-吡咯啶酮羧酸鹽等胍衍生物等,可由此等當中選擇1種或2種以上。又,此等的鹽可舉出例如鹵素、甲基硫酸鹽、乙基硫酸鹽及甲基磷酸鹽等。In addition, as for the component (B) of the present invention, as long as it is cationic in the composition, it may also be the skeleton of an amphoteric surfactant. As such a surfactant, one having an amino acid residue is preferred, and it is preferred that the amino acid residue is a basic amino acid residue. Specifically, stearinyl lysine butyl ester·hydrochloride, N-cocoyl-L-arginine ethyl ester pyrrolidone carboxylate, lauryl-ornithine acid Mono-N-long-chain acyl basic amino acid lower alkyl ester salts such as propyl esters and anhydrides; decyl guanidine acid salt, 2-guanidinoethyl lauryl amide hydrochloride, 2-guanidino Guanidine derivatives such as butylstearylamine, DL-pyrrolidone carboxylate, etc. can be selected from one or more of them. In addition, examples of these salts include halogen, methyl sulfate, ethyl sulfate, and methyl phosphate.

此等當中,基於穩定性觀點,較佳為四級銨鹽及單-N-長鏈醯基鹼性胺基酸低級烷基酯鹽;四級銨鹽中,較佳為氯化烷基三甲銨、二長鏈醯基烷基羥烷基銨;單-N-長鏈醯基鹼性胺基酸低級烷基酯鹽中,較佳為N-椰油醯基-L-精胺酸乙基酯吡咯啶酮羧酸鹽。更具體而言,可使用與其他水性成分的混合物,而作為此種市售品,可舉出山嵛基三甲基氯化銨的混合物之GENAMIN KDMP(Clariant Japan公司製;純量81.5%)、二椰油醯乙基羥乙基甲基銨甲基硫酸鹽的混合物之DEHYQUART L80 T(BASF公司製:純分80%)、二棕櫚醯乙基羥乙基甲基銨甲基硫酸鹽的混合物之DEHYQUART AU56/G、DEHYQUART C4046(皆為BASF公司製)、N-椰油醯基-L-精胺酸乙基酯吡咯啶酮羧酸鹽之CAE(味之素公司製)等。其中,尤其若是二長鏈醯基烷基羥烷基銨這類雙鏈型界面活性劑,則可自行形成囊泡粒子,而進一步提升皮膚滲透性,且歷時穩定性亦優良而較佳。Among them, from the viewpoint of stability, quaternary ammonium salts and mono-N-long-chain acyl basic amino acid lower alkyl ester salts are preferred; among the quaternary ammonium salts, alkyltrimethyl chloride is preferred. Ammonium, di-long-chain acyl alkylhydroxyalkyl ammonium; mono-N-long-chain acyl basic amino acid lower alkyl ester salt, preferably N-cocoyl-L-arginine ethyl Base ester pyrrolidone carboxylate. More specifically, a mixture with other aqueous components can be used, and as such a commercially available product, GENAMIN KDMP (manufactured by Clariant Japan Co., Ltd.; pure weight 81.5%) which is a mixture of behenyltrimethylammonium chloride can be mentioned. , DEHYQUART L80 T (manufactured by BASF: 80% pure), a mixture of two coconut oil ethyl hydroxyethyl methyl ammonium methyl sulfate, two palm oil ethyl hydroxyethyl methyl ammonium methyl sulfate The mixture of DEHYQUART AU56/G, DEHYQUART C4046 (all made by BASF), N-cocoyl-L-arginine ethyl ester pyrrolidone carboxylate CAE (made by Ajinomoto), etc. Among them, especially if it is a double-chain type surfactant such as a two-long chain alkylalkylhydroxyalkylammonium, it can form vesicle particles by itself to further improve skin permeability, and it is also preferable that it has excellent stability over time.

本發明中之成分(B)的含量,基於對肌膚的滲透性或安全性觀點,約較佳為0.001~0.1%,更佳為0.002~0.05%,特佳為0.02~0.05%。The content of the component (B) in the present invention, based on the skin permeability or safety viewpoint, is preferably about 0.001 to 0.1%, more preferably 0.002 to 0.05%, particularly preferably 0.02 to 0.05%.

於本發明中,成分(A)與成分(B)的含有質量比(A)/(B)不特別限定,基於作為皮膚外用劑的使用性觀點,係10~500,較佳為25~300,更佳為25~200。若為此範圍,使用時無黏膩感,且可良好地感到滲透感或塗敷後肌膚之緊緻感。In the present invention, the content mass ratio (A)/(B) of the component (A) to the component (B) is not particularly limited. From the viewpoint of usability as an external preparation for skin, it is 10 to 500, preferably 25 to 300 , More preferably 25~200. If it is within this range, there is no sticky feeling during use, and a good feeling of penetration or firmness of the skin after application can be felt.

本發明所使用之成分(C)之陰離子性高分子係具有陰離子性的高分子,只要是一般作為化妝料使用者則不特別限定。具體而言,可舉出海藻酸、玻尿酸、阿拉伯膠、鹿角菜膠、硫酸軟骨素、明膠、羧甲基纖維素、羧基乙烯聚合物、聚丙烯酸等水溶性高分子及彼等之衍生物等,可使用此等當中的1種或2種以上。此外,此等可隨天然或合成等來源的不同而異,不特別限定。The anionic polymer of the component (C) used in the present invention is an anionic polymer, and it is not particularly limited as long as it is generally used as cosmetics. Specifically, water-soluble polymers such as alginic acid, hyaluronic acid, gum arabic, carrageenan, chondroitin sulfate, gelatin, carboxymethyl cellulose, carboxyvinyl polymer, polyacrylic acid, and their derivatives can be cited , One or two or more of these can be used. In addition, these may vary depending on natural or synthetic sources, and are not particularly limited.

其中,於本發明中,基於使用時無黏膩感及塗敷後肌膚之緊緻感優良之觀點,較佳為羧基乙烯聚合物及/或烷基改性羧基乙烯聚合物。此處所稱「羧基乙烯聚合物」,係指包含至少具有聚合性乙烯基與羧基或烷基改性羧基之聚合性單體作為構成單元之聚合物的總稱。此處所稱「烷基改性」,係指一部分或全部羧基經烷基酯化者,例如包含至少1種丙烯酸酯類或甲基丙烯酸酯類作為構成單體之聚合物係包含於經烷基改性之羧基乙烯聚合物的實例。烷基改性之烷基的碳數不予限定,較佳為10以上30以下,更佳為18以上24以下。烷基改性羧基乙烯聚合物之市售品可舉出CARBOPOL1342、CARBOPOL1382(以上為LUBRIZOL ADVANNCED MATERIALS公司製)、Pemulen TR-1、Pemulen TR-2(以上為NOVEON公司製)等;羧基乙烯聚合物之市售品可舉出CARBOPOL940、CARBOPOL941、CARBOPOL980、CARBOPOL934(以上為LUBRIZOL ADVANNCED MATERIALS公司製)、AQUPEC HV-501(住友精化公司製)等。Among them, in the present invention, the carboxyvinyl polymer and/or the alkyl-modified carboxyvinyl polymer are preferred from the viewpoints of no stickiness during use and excellent firmness of the skin after application. The term "carboxyvinyl polymer" as used herein refers to a general term for polymers containing polymerizable monomers having at least a polymerizable vinyl group and a carboxyl group or an alkyl-modified carboxyl group as constituent units. The term "alkyl modification" as used herein refers to those in which part or all of the carboxyl groups are esterified with alkyl. For example, polymers containing at least one acrylate or methacrylate as constituent monomers are contained in the Examples of modified carboxyvinyl polymers. The carbon number of the alkyl-modified alkyl group is not limited, and is preferably 10 or more and 30 or less, and more preferably 18 or more and 24 or less. Commercial products of alkyl-modified carboxyvinyl polymers include CARBOPOL1342, CARBOPOL1382 (the above are manufactured by LUBRIZOL ADVANNCED MATERIALS), Pemulen TR-1, Pemulen TR-2 (the above are manufactured by NOVEON), etc.; carboxyvinyl polymers Commercial products include CARBOPOL940, CARBOPOL941, CARBOPOL980, CARBOPOL934 (the above are manufactured by LUBRIZOL ADVANNCED MATERIALS), AQUPEC HV-501 (manufactured by Sumitomo Seiki), and the like.

本發明中之成分(C)的摻混量,只要是一般使用於化妝料的摻混量則不特別限定,基於與成分(B)的交互作用之觀點,較佳處於0.001~10%,較佳為0.01~5%,且更佳為0.05~1%,特佳為0.05~0.2%的範圍。若為此範圍,則可提供穩定性優良或使用時無黏膩感、塗敷後肌膚之緊緻感優良的皮膚外用劑。The blending amount of component (C) in the present invention is not particularly limited as long as it is a blending amount generally used in cosmetics. Based on the viewpoint of the interaction with component (B), it is preferably 0.001 to 10%. It is preferably 0.01 to 5%, more preferably 0.05 to 1%, particularly preferably 0.05 to 0.2%. If it is within this range, it is possible to provide an external preparation for skin with excellent stability, no stickiness during use, and excellent firmness of the skin after application.

於本發明中,成分(A)與成分(C)的含有質量比(A)/(C)不特別限制,係5.0~150,較佳為5.0~125,更佳為10~100。若為此範圍,則無黏膩感,且塗敷後肌膚之緊緻感亦更優良。又,成分(B)與成分(C)的含有質量比(B)/(C)不特別限制,較佳為0.01~10,更佳為0.05~5,再更佳為0.1~1,特佳為0.2~0.6。若為此範圍,則凝聚抑制效果更優良。In the present invention, the content mass ratio (A)/(C) of the component (A) to the component (C) is not particularly limited, and is 5.0 to 150, preferably 5.0 to 125, and more preferably 10 to 100. If it is within this range, there will be no stickiness, and the skin's firmness after application will be better. In addition, the content mass ratio (B)/(C) of the component (B) and the component (C) is not particularly limited, but is preferably 0.01 to 10, more preferably 0.05 to 5, and still more preferably 0.1 to 1, especially preferred It is 0.2~0.6. Within this range, the aggregation suppression effect is more excellent.

本發明所使用之成分(D)水,只要是一般使用於化妝料等者則不特別限制。除純水外,在不損及本發明之效果的範圍,亦可為深層水,或者玫瑰水或薰衣草水等植物的水蒸氣蒸餾水,可視需求適宜選擇一種或二種以上來使用。 又,本發明中之成分(D)的摻混量,只要是一般使用於化妝料的摻混量則不特別限定,較佳為30~95%。The component (D) water used in the present invention is not particularly limited as long as it is generally used for cosmetics and the like. In addition to pure water, deep water, or steam distilled water from plants such as rose water or lavender water can also be used within a range that does not impair the effects of the present invention. One or two or more of them can be appropriately selected for use according to requirements. In addition, the blending amount of the component (D) in the present invention is not particularly limited as long as it is a blending amount generally used for cosmetics, and it is preferably 30 to 95%.

再者,於本發明中,成分(E)若使用親水性之非離子性界面活性劑,則可抑制成分(B)與成分(C)的凝聚。作為成分(E),係HLB10~18的非離子性界面活性劑,更佳為HLB11~16者。此外,本發明中所使用之HLB(親水-親油平衡;Hydrophile-Lypophile Balance)值係根據格里芬法所得的值。具體而言,可舉出聚甘油脂肪酸酯、蔗糖脂肪酸酯、聚氧乙烯山梨醇酐脂肪酸酯、聚氧乙烯山梨醇脂肪酸酯、聚氧乙二醇脂肪酸酯、聚氧乙二醇脂肪酸酯、聚氧乙烯烷基醚、聚氧乙烯聚氧丙烯烷基醚、聚氧乙烯硬化蓖麻油、聚氧乙烯脂肪酸乙醇醯胺、聚氧乙烯膽固醇醚、聚氧乙烯二氫膽固醇醚、聚氧乙烯植物固醇醚、聚氧乙烯植物甾烷醇醚(polyoxyethylene phytostanol ether)、聚氧乙烯烷基醚、丙二醇脂肪酸酯、聚氧伸烷基改性聚矽氧、聚氧伸烷基烷基共改性聚矽氧等,可使用此等的1種或2種以上。其中,較佳為具有聚氧乙烯基之非離子性界面活性劑,較佳為環氧乙烷之平均加成莫耳數為5~100的非離子界面活性劑,更佳為10~80。Furthermore, in the present invention, if a hydrophilic nonionic surfactant is used for the component (E), the aggregation of the component (B) and the component (C) can be suppressed. As component (E), it is a nonionic surfactant of HLB10-18, more preferably HLB11-16. In addition, the HLB (Hydrophile-Lypophile Balance) value used in the present invention is a value obtained according to the Griffin method. Specifically, polyglycerol fatty acid esters, sucrose fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene glycol fatty acid esters, polyoxyethylene two Alcohol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene hardened castor oil, polyoxyethylene fatty acid glycolamide, polyoxyethylene cholesterol ether, polyoxyethylene dihydrocholesterol ether , Polyoxyethylene phytostanol ether, polyoxyethylene phytostanol ether, polyoxyethylene alkyl ether, propylene glycol fatty acid ester, polyoxyalkylene modified polysiloxane, polyoxyethylene phytostanol ether Alkyl alkyl co-modified polysiloxane, etc., one kind or two or more kinds of these can be used. Among them, a nonionic surfactant having a polyoxyethylene group is preferable, and a nonionic surfactant having an average addition molar number of ethylene oxide of 5-100 is preferable, and 10-80 is more preferable.

成分(E)可使用市售品,係例如單油酸聚氧乙烯山梨醇酐(20E.O.)之RHEODOL TW-O120V(花王公司製)、Nonion OT-221(日油公司製)、單硬脂酸聚氧乙烯山梨醇酐(20E.O.)之RHEODOL TW-S120V(花王公司製)、Nonion ST-221(日油公司製)、聚氧乙烯聚氧丙烯癸基十四基醚(20E.O.)之NIKKOL PEN-4620(Nikko Chemicals公司製)之EMALEX PS-30(NIHON EMULSION公司製)、NIKKOL BPS-30(Nikko Chemicals公司製)、聚氧乙烯硬化蓖麻油(60E.O.)之EMALEX HC-60(NIHON EMULSION公司製)、NIKKOL HCO-60(Nikko Chemicals公司製)、聚氧伸烷基改性有機聚矽氧烷,可例示KF-6011、KF-6011P、KF-6018、KF-6043(皆為信越化學工業公司製)、NUC Silicone SS-2802(Dow Corning Toray公司製)等。Component (E) can use commercially available products, such as RHEODOL TW-O120V (manufactured by Kao Corporation), Nonion OT-221 (manufactured by NOF Corporation), monooleic acid polyoxyethylene sorbitan (20E.O.) RHEODOL TW-S120V (manufactured by Kao Corporation), Nonion ST-221 (manufactured by NOF Corporation), polyoxyethylene polyoxypropylene decyl tetradecyl ether ( 20E.O.) of NIKKOL PEN-4620 (manufactured by Nikko Chemicals), EMALEX PS-30 (manufactured by NIHON EMULSION), NIKKOL BPS-30 (manufactured by Nikko Chemicals), polyoxyethylene hardened castor oil (60E.O. ) Of EMALEX HC-60 (manufactured by NIHON EMULSION), NIKKOL HCO-60 (manufactured by Nikko Chemicals), polyoxyalkylene modified organopolysiloxane, such as KF-6011, KF-6011P, KF-6018 , KF-6043 (all manufactured by Shin-Etsu Chemical Co., Ltd.), NUC Silicone SS-2802 (manufactured by Dow Corning Toray Co., Ltd.), etc.

本發明中之成分(E)的含量不特別限定,較佳為0.01~10%,更佳為0.05~8%,再更佳為0.1~6%,尤以0.5~6%為佳。若為此範圍,則可進一步抑制成分(B)與成分(C)的凝聚,而能夠獲得長期呈穩定的皮膚外用劑。The content of the component (E) in the present invention is not particularly limited, and is preferably 0.01-10%, more preferably 0.05-8%, still more preferably 0.1-6%, particularly preferably 0.5-6%. Within this range, the aggregation of the component (B) and the component (C) can be further suppressed, and a skin external preparation that is stable for a long period of time can be obtained.

於本發明中,成分(E)相對於成分(B)與成分(C)之總含有質量的比(E)/[(B)+(C)]不特別限定,基於成分(B)與成分(C)的凝聚抑制效果、使用時無黏膩感或滲透感良好,係0.1~150,較佳為0.5~100,更佳為1.0~80。In the present invention, the ratio (E)/[(B)+(C)] of component (E) to the total content of component (B) and component (C) is not particularly limited, and is based on component (B) and component (C) The agglomeration inhibitory effect, no sticky feeling or good penetrating feeling during use, is 0.1 to 150, preferably 0.5 to 100, and more preferably 1.0 to 80.

再者,於本發明中,透過成分(B)構成囊泡粒子,可提升電荷所產生的吸附性及作為皮膚外用劑的滲透性,且可進一步相乘性地發揮成分(A)及其他有效成分之效果。諸如前述,成分(B)之界面活性劑若為雙鏈型,則其單獨可形成囊泡,或者併用如磷脂質或二(月桂醯胺麩胺酸)離胺酸鈉之其他囊泡膜構成成分與成分(B),則亦可形成含有陽離子性界面活性劑的囊泡粒子。此等當中,基於安全性觀點,可較佳使用磷脂質。又,囊泡粒子的形成方法不特別限制,可根據習知方法來製造;囊泡粒子的確認方法,可使用偏光顯微鏡根據在正交偏光下有無馬耳他十字影像等來進行。使用磷脂質時,磷脂質的含量不特別限制,較佳為0.01~5%,更佳為0.05~1%,特佳為0.1~0.5%。Furthermore, in the present invention, the vesicle particles are formed by the component (B), which can improve the adsorption of electric charge and the permeability as an external preparation for skin, and can further exert the component (A) and other effects synergistically. The effect of the ingredients. As mentioned above, if the surfactant of component (B) is of double-stranded type, it can form vesicles alone, or be combined with other vesicle membranes such as phospholipids or bis(laurylamine glutamate) sodium lysine Component and component (B) can also form vesicle particles containing a cationic surfactant. Among these, phospholipids can be preferably used from the viewpoint of safety. In addition, the method of forming vesicle particles is not particularly limited, and can be produced according to conventional methods; the method of confirming vesicle particles can be performed using a polarizing microscope based on the presence or absence of Maltese cross images under cross-polarized light. When phospholipids are used, the content of phospholipids is not particularly limited, and is preferably 0.01 to 5%, more preferably 0.05 to 1%, and particularly preferably 0.1 to 0.5%.

又,本發明之皮膚外用劑的pH不特別限制,25℃的pH較佳為4.0~7.5的範圍內。In addition, the pH of the external preparation for skin of the present invention is not particularly limited, and the pH at 25°C is preferably in the range of 4.0 to 7.5.

本發明之皮膚外用劑中,除上述成分(A)~(E)以外,亦可在不損及本發明之效果的範圍適宜含有一般使用於皮膚外用劑的成分。例如,可含有高級醇、烴油、酯油、蠟類、聚矽氧油等油劑、界面活性劑、水溶性高分子、多元醇、低級醇等水性成分、紫外線吸收劑、抗氧化劑、抗菌劑、防腐劑、保濕劑、pH調整劑、清涼劑、粉體、維生素類、美容成分、香料等。 如示出本發明皮膚外用劑之較佳組成的一樣態,則如以下所示: 成分   較佳        更佳            再更佳         特佳 (A)    1~10%       3~10%         4~9%           4~9% (B)    0.001~0.1% 0.002~0.05% 0.02~0.05%   0.02~0.05% (C)    0.001~10%  0.01~5%       0.05~1%       0.05~0.2% (D)    30~95%      30~95%        30~95%        30~95% (E)    0.01~10%   0.05~8%       0.1~6%        0.5~6%In addition to the above-mentioned components (A) to (E), the external preparation for skin of the present invention may suitably contain components generally used for external preparations for skin within a range that does not impair the effects of the present invention. For example, it may contain higher alcohols, hydrocarbon oils, ester oils, waxes, silicone oils and other oils, surfactants, water-soluble polymers, polyols, lower alcohols and other water-based components, ultraviolet absorbers, antioxidants, antibacterial Agents, preservatives, moisturizers, pH adjusters, cooling agents, powders, vitamins, beauty ingredients, fragrances, etc. For example, the preferred composition of the external preparation for skin of the present invention is shown as follows: Composition better (A) 1~10% 3~10% 4~9% 4~9% (B) 0.001~0.1% 0.002~0.05% 0.02~0.05% 0.02~0.05% (C) 0.001~10% 0.01~5% 0.05~1% 0.05~0.2% (D) 30~95% 30~95% 30~95% 30~95% (E) 0.01~10% 0.05~8% 0.1~6% 0.5~6%

本發明之皮膚外用劑的製造方法不特別限定,可藉由常用方法來調製。可舉出例如將成分(B)與視需求而定的其他成分加熱溶解後,添加混合於經均勻地溶解混合之成分(A)、(C)~(E),進而視需求上述任意成分,並將其混合而調製的方法。The method for producing the external preparation for skin of the present invention is not particularly limited, and can be prepared by a common method. For example, after heating and dissolving the component (B) and other components as required, the components (A), (C) to (E) that are uniformly dissolved and mixed are added and mixed, and then any of the above-mentioned components as required, And it is a method of mixing and modulating.

本發明之皮膚外用劑能以液狀、凝膠狀、乳膏狀等各種形態實施,且劑型為溶解型、水中油型、油中水型、油性型、水中油中水型、油中水中油型、多層型等,不特別限定。就穩定性觀點,在低黏度或者半透明之性質狀態下,可切身感受本發明之效果而較佳。The external preparation for skin of the present invention can be implemented in various forms such as liquid, gel, cream, etc., and the dosage forms are dissolved, oil in water, water in oil, oily, oil in water, water in oil, and water in oil. Oil type, multilayer type, etc. are not particularly limited. From the standpoint of stability, it is better to feel the effects of the present invention in a low viscosity or translucent state.

此外,本發明之皮膚外用劑可作成皮膚用化妝料而利用,可例示例如化妝水、乳液、乳霜、美容液、按摩料、面膜料、護手霜、美體水(body lotion)、美體霜、防曬劑、粉底、眼影、眼線、遮瑕膏、頭皮用修補素(treatment)等。由可切身感受其效果而言,較佳為護膚化妝料;就其使用方法,可舉出以手、手指或化妝棉使用之方法、含浸於不織布等而使用之方法、直接噴霧而使用之方法等。於本發明之皮膚外用劑的較佳樣態中,可排除例如洗髮精、潤絲精、護髮素、髮蠟等專用於毛髮的毛髮化妝料。 [實施例]In addition, the external preparation for skin of the present invention can be used as cosmetics for skin. Examples include lotions, lotions, creams, beauty liquids, massage materials, facial masks, hand creams, body lotions, and body creams. , Sunscreen, foundation, eye shadow, eyeliner, concealer, scalp treatment, etc. It is better to use skin care cosmetics in terms of being able to feel its effects personally. The method of use can include the method of using hands, fingers or cotton pads, the method of impregnating non-woven fabrics, etc., and the method of direct spraying. Wait. In the preferred aspect of the external skin preparation of the present invention, hair cosmetics dedicated to hair, such as shampoo, conditioner, conditioner, wax, etc., can be excluded. [Example]

以下,為了具體說明本發明而舉出實施例,惟本發明非限定於此等實施例等。又,除非特別明記,否則含量係以相對於含有該成分之組成物的質量%表示。Hereinafter, in order to specifically describe the present invention, examples are given, but the present invention is not limited to these examples and the like. In addition, unless otherwise specified, the content is expressed in% by mass relative to the composition containing the component.

實施例1~11及比較例1~4:美容液 根據下述製造方法製造表1所示組成之美容液,並針對A:凝聚抑制效果、B:滲透感、C:有無黏膩感、D:塗敷後肌膚之緊緻感,根據以下所示方法進行評定判定。將結果一併示於表1。Examples 1 to 11 and comparative examples 1 to 4: beauty lotion The beauty serum of the composition shown in Table 1 was produced according to the following manufacturing method, and A: aggregation inhibition effect, B: penetration, C: stickiness, D: skin firmness after application, according to the following Method for evaluation and judgment. The results are shown in Table 1.

Figure 02_image001
Figure 02_image001

(製造方法) A:將成分(1)、(2)、(5)~(11)及(16)以75℃均勻地加熱溶解。 B:將成分(3)、(4)、(12)~(15)以75℃均勻地加熱溶解。 C:於75℃下對B添加A,並加以攪拌而得到美容液。(Production method) A: The components (1), (2), (5) to (11), and (16) are uniformly heated and dissolved at 75°C. B: The components (3), (4), (12) to (15) are uniformly heated and dissolved at 75°C. C: A was added to B at 75°C and stirred to obtain a beauty lotion.

(評定方法1) (A.凝聚抑制效果) 就凝聚抑制效果,係以將實施例1~11及比較例1~4之美容液用水稀釋10倍時的透明性來評定。經確認該透明性可確保長期穩定性。 分別在玻璃製燒杯中量取1.0g的組成物,使用純水稀釋10倍並攪拌至獲得均勻的溶液。此時係使用金屬製軟膏刮鏟用手混合來攪拌。將所得試樣填充於光徑長10mm×光徑寬5mm的玻璃樣品槽,以分光光度計(UV-2500PC SHIMADZU公司製)測定波長700nm的穿透率。 <判定基準> (判定):(評定) ◎:穿透率為55%以上(室溫保存1個月後,無凝聚、沉澱) △:穿透率為45~55%(室溫保存1個月後,約略可看出凝聚、沉澱、濁度變化) ×:穿透率未達45%(室溫保存1個月後,可見凝聚、沉澱、濁度變化)(Assessment method 1) (A. Aggregation suppression effect) The aggregation inhibitory effect was evaluated by the transparency when the beauty liquids of Examples 1 to 11 and Comparative Examples 1 to 4 were diluted 10 times with water. It has been confirmed that this transparency can ensure long-term stability. Each of 1.0 g of the composition was measured in a glass beaker, diluted 10 times with pure water, and stirred until a uniform solution was obtained. At this time, a metal ointment spatula was used to mix and stir by hand. The obtained sample was filled in a glass sample cell having an optical path length of 10 mm × an optical path width of 5 mm, and the transmittance at a wavelength of 700 nm was measured with a spectrophotometer (manufactured by UV-2500PC SHIMADZU). <Judgment Criteria> (Judgment): (Assessment) ◎: The penetration rate is more than 55% (after 1 month storage at room temperature, there is no aggregation or precipitation) △: The penetration rate is 45~55% (after one month of storage at room temperature, agglomeration, precipitation, and turbidity changes can be seen approximately) ×: The penetration rate is less than 45% (after one month of storage at room temperature, changes in aggregation, precipitation, and turbidity can be seen)

(評定方法2) 由20多歲~40多歲的女性接受官能評定訓練,選出10位可根據既定基準進行評定的專業官能檢查員。請該專業官能檢查員於前腕使用各試料,並針對各者,將使用時所感受到的滲透感、有無黏膩感及塗敷後肌膚之緊緻感,依下述絕對評定按5等級進行評定並評分。依各試料,由全體官能檢查員的評分合計算出其平均值,根據下述4等級判定基準進行判定。(Assessment method 2) Women in their 20s to 40s receive sensory assessment training, and 10 professional sensory inspectors who can perform assessments based on established standards are selected. Ask the professional sensory inspector to use each sample on the front wrist, and for each individual, evaluate the penetration, stickiness, and firmness of the skin after application according to the following absolute evaluation according to 5 levels And score. For each sample, the average value was calculated from the scores of all the sensory inspectors, and judged according to the following four-level judgment criteria.

(B:滲透感) <絕對評定基準> (評分):(評定) 5分:感覺有化妝水對肌膚的滲透感 4分:略感覺有化妝水對肌膚的滲透感 3分:普通 2分:幾乎未感覺有化妝水對肌膚的滲透感 1分:未感覺有化妝水對肌膚的滲透感 <4等級判定基準> (就以下的評定項目亦同) (判定):(評分的平均分數) ◎:4.5分以上      :極為良好 ○:3.5分以上且未達4.5分 :良好 △:1.5分以上且未達3.5分 :略為不良 ×:未達1.5分      :不良(B: Permeability) <Absolute evaluation standard> (Rating): (rating) 5 points: I feel that the lotion penetrates the skin 4 points: Slightly feel the penetration of the lotion into the skin 3 points: normal 2 points: There is almost no permeation of the lotion into the skin 1 point: No feeling of penetration of the lotion into the skin <4 grade judgment standard> (The same applies to the following assessment items) (Judgment): (Average score of scoring) ◎: 4.5 points or more       : extremely good ○: 3.5 points or more and less than 4.5 points: good △: 1.5 points or more and less than 3.5 points: slightly bad ×: less than 1.5 points       : bad

(C:有無黏膩感) <絕對評定基準> (評分):(評定) 5分:無黏膩感 4分:幾無黏膩感 3分:略有黏膩感 2分:有黏膩感 1分:黏膩感極強(C: Does it feel sticky) <Absolute evaluation standard> (Rating): (rating) 5 points: no stickiness 4 points: almost no stickiness 3 points: slightly sticky 2 points: sticky 1 point: extremely sticky

(D:塗敷後肌膚之緊緻感) <絕對評定基準> (評分):(評定) 5分:感覺有肌膚之緊緻感 4分:略感覺有肌膚之緊緻感 3分:普通 2分:幾乎未感覺有肌膚之緊緻感 1分:未感覺有肌膚之緊緻感(D: Skin firmness after application) <Absolute evaluation standard> (Rating): (rating) 5 points: I feel the firmness of the skin 4 points: I feel a little firmness of the skin 3 points: normal 2 points: There is almost no skin firmness 1 point: No skin firmness is felt

由表1之結果可知,實施例1~11之美容液,相較於比較例1~4之美容液,凝聚抑制效果、滲透感、無黏膩感、塗敷後肌膚之緊緻感較優良。 另一方面,不含成分(A)的比較例1,塗敷後肌膚之緊緻感較差。將成分(A)變更為其他對皮膚有益之用劑(甘草酸二鉀)的比較例2,凝聚抑制效果、無黏膩感、塗敷後肌膚之緊緻感較差。成分(A)為0.5%的比較例3,亦同樣地無法感到塗敷後肌膚之緊緻感,而成分(A)為15%的比較例4,由於菸鹼醯胺過多,不易感到滲透感,且產生了黏膩感。From the results in Table 1, it can be seen that the beauty serums of Examples 1 to 11 have better aggregation inhibition effect, penetration, no stickiness, and firmness of the skin after application compared to the beauty serums of Comparative Examples 1 to 4 . On the other hand, in Comparative Example 1, which does not contain the component (A), the skin feels less firm after application. In Comparative Example 2 in which ingredient (A) was changed to another skin-beneficial agent (dipotassium glycyrrhizinate), the aggregation inhibitory effect, no stickiness, and skin firmness after application were poor. Comparative Example 3 with a 0.5% ingredient (A) also failed to feel the firmness of the skin after application, while Comparative Example 4 with a 15% ingredient (A) had too much nicotine amide, which made it difficult to feel the penetrating sensation. , And produced a sticky feeling.

實施例12:化妝水 (成分)                                             (%) (1)氯化烷基三甲銨 (註2)                    0.1 (2)氫化大豆磷脂質 (註7)                    0.5 (3)1,3-丁二醇                                   5.0 (4)單油酸聚氧乙烯山梨醇酐(20E.O.)     1.0 (5)香料                                           適量 (6)乙醇                                           10.0 (7)防腐劑                                        適量 (8)菸鹼醯胺                                     5.0 (9)傳明酸                                        2.0 (10)聚氧乙烯甘油(26E.O.)                   2.0 (11)聚氧乙烯甲基葡萄糖苷 (註8)        2.0 (12)(丙烯酸酯/丙烯酸烷基酯(C10-C30))交聯共聚物(註3)    0.1 (13)羧基乙烯聚合物                           0.1 (14)氫氧化鈉                                    0.05 (15)純水                                          餘量 (註8)Macbiobride MG-10E(日油公司製)Example 12: Toner (Element) (%) (1) Alkyl trimethylammonium chloride (Note 2) 0.1 (2) Hydrogenated soybean phospholipids (Note 7) 0.5 (3) 1,3-Butanediol 5.0 (4) Monooleic acid polyoxyethylene sorbitan anhydride (20E.O.) 1.0 (5) Perfume in proper amount (6) Ethanol 10.0 (7) Preservatives Appropriate amount (8) Nicotine amine 5.0 (9) Chuanming acid 2.0 (10) Polyoxyethylene glycerin (26E.O.) 2.0 (11) Polyoxyethylene methyl glucoside (Note 8) 2.0 (12) (Acrylate/alkyl acrylate (C10-C30)) crosslinked copolymer (Note 3) 0.1 (13) Carboxy vinyl polymer 0.1 (14) Sodium hydroxide 0.05 (15) Pure water balance (Note 8) Macbiobride MG-10E (manufactured by NOF Corporation)

(製造方法) A:將成分(1)~(3)以75℃均勻地溶解混合。 B:一邊將前述A保持於75℃一邊添加一部分的成分(15),並以Disper mixer攪拌而得到囊泡分散液。 C:將成分(4)~(15)以室溫均勻地溶解混合。 D:對前述C添加混合冷卻至35℃的前述B而得到化妝水。 如以上所得之化妝水,其凝聚抑制效果、滲透感、無黏膩感、塗敷後肌膚之緊緻感優良。(Production method) A: The components (1) to (3) are uniformly dissolved and mixed at 75°C. B: While maintaining the aforementioned A at 75°C, a part of the component (15) was added and stirred with a Disper mixer to obtain a vesicle dispersion. C: The components (4) to (15) are uniformly dissolved and mixed at room temperature. D: The aforementioned B cooled to 35°C is added and mixed to the aforementioned C to obtain a lotion. The lotion obtained above has excellent aggregation inhibition effect, penetrating feel, non-sticky feel, and excellent firmness of the skin after application.

實施例13:透明化妝水 (成分)                                                  (%) (1)異硬脂酸聚氧乙烯(50)硬化蓖麻油           0.2 (2)PEG-10甲基醚聚二甲基矽氧烷 (註4)       0.1 (3)二椰油醯乙基羥乙基甲基銨甲基硫酸鹽        0.01 (4)氯化烷基三甲銨                                  0.01 (5)油酸乙酯                                           0.05 (6)2-乙基己酸十六酯                               0.05 (7)香料                                                 適量 (8)乙醇                                                 1.0 (9)1,3-丁二醇                                         5.0 (10)甘油                                               5.0 (11)二甘油                                            2.0 (12)聚氧丁烯聚氧乙烯聚氧丙烯甘油醚 (3E.O.) (註9)                                     3.0 (13)菸鹼醯胺                                         5.0 (14)羧基乙烯聚合物                                0.1 (15)氫氧化鈉                                         0.05 (16)傳明酸                                            1.0 (17)氫氧化鈉                                         0.05 (18)防腐劑                                            適量 (19)香料                                               適量 (20)純水                                               餘量 (註9)WILBRIDE S-753D(日油公司製)Example 13: Transparent lotion (Element) (%) (1) Isostearic acid polyoxyethylene (50) Hardened castor oil 0.2 (2) PEG-10 methyl ether polydimethylsiloxane (Note 4) 0.1 (3) Two coconut oil ethyl hydroxyethyl methyl ammonium methyl sulfate 0.01 (4) Alkyl trimethylammonium chloride 0.01 (5) Ethyl oleate 0.05 (6) hexadecyl 2-ethylhexanoate 0.05 (7) Perfume in proper amount (8) Ethanol 1.0 (9) 1,3-Butanediol 5.0 (10) Glycerin 5.0 (11) Diglycerol 2.0 (12) Polyoxybutylene polyoxyethylene polyoxypropylene glycerol ether (3E.O.) (Note 9) 3.0 (13) Nicotine amine 5.0 (14) Carboxy vinyl polymer 0.1 (15) Sodium hydroxide 0.05 (16) Chuanming acid 1.0 (17) Sodium hydroxide 0.05 (18) Preservatives Appropriate amount (19) Perfume in proper amount (20) Pure water balance (Note 9) WILBRIDE S-753D (manufactured by NOF Corporation)

(製造方法) A:將成分(1)~(10)以70℃均勻地溶解混合。 B:將成分(11)~(20)以室溫均勻地溶解混合。 C:將前述A添加於B,於室溫下使其溶化而得到透明化妝水。 如以上所得之透明化妝水,其凝聚抑制效果、滲透感、無黏膩感、塗敷後肌膚之緊緻感優良。(Production method) A: The components (1) to (10) are uniformly dissolved and mixed at 70°C. B: The components (11) to (20) are uniformly dissolved and mixed at room temperature. C: The aforementioned A is added to B, and it is melted at room temperature to obtain a transparent lotion. The transparent lotion obtained above has excellent aggregation inhibition effect, penetrating feel, non-sticky feel, and excellent firmness of the skin after application.

實施例14:水中油乳化型美容液 (成分)                                                 (%) (1)聚甘油-10 (二十烷二酸/十四烷二酸)酯   1.5 (2)三丙二醇                                          15.0 (3)菸鹼醯胺                                          6.0 (4)L-茶胺酸                                          0.05 (5)1,3-丁二醇                                             3.5 (6)二丙二醇                                          0.5 (7)純水                                                餘量 (8)甘油                                                2.0 (9)聚乙二醇                                          2.0 (10)傳明酸                                           2.0 (11)磷酸氫鈉                                        0.3 (12)磷酸二氫鈉                                     0.6 (13)乙二胺四乙酸二鈉                            0.02 (14)對羥基苯甲酸甲酯                            0.1 (15)異硬脂酸聚氧乙烯(50)硬化蓖麻油         0.2 (16)聚氧乙烯(60)硬化蓖麻油                    0.2 (17)二椰油醯乙基羥乙基甲基銨甲基硫酸鹽    0.01 (18)乙醇                                              5.0 (19)L-薄荷醇                                        0.02 (20)肉豆蔻酸異丙酯                               0.3 (21)二聚物二亞麻油酸(植物固醇酯/異十八酯/十六酯/十八酯/二十二酯 (註10)                                  0.2 (22)油酸山梨醇酐                                  0.2 (23)生育三烯酚                                     0.02 (24)羧基乙烯聚合物                               0.02 (25)(丙烯酸酯/丙烯酸烷基酯(C10-30))交聯共聚物 (註3)                                                    0.02 (26)黃原膠                                           0.01 (27)氫氧化鈉                                        0.01 (28)水解玻尿酸                                     0.01 (註10)PLANDOOL-S(日本精化公司製)Example 14: Oil-in-water emulsified beauty liquid (Element) (%) (1) Polyglycerol-10 (eicosandioic acid/tetradecanedioic acid) ester 1.5 (2) Tripropylene glycol 15.0 (3) Nicotine amine 6.0 (4) L-theanine acid 0.05 (5) 1,3-Butanediol 3.5 (6) Dipropylene glycol 0.5 (7) Pure water balance (8) Glycerin 2.0 (9) Polyethylene glycol 2.0 (10) Chuanming acid 2.0 (11) Sodium hydrogen phosphate 0.3 (12) Sodium dihydrogen phosphate 0.6 (13) Disodium ethylenediaminetetraacetic acid 0.02 (14) Methyl paraben 0.1 (15) Isostearic acid polyoxyethylene (50) Hardened castor oil 0.2 (16) Polyoxyethylene (60) Hardened castor oil 0.2 (17) Two coconut oil ethyl hydroxyethyl methyl ammonium methyl sulfate 0.01 (18) Ethanol 5.0 (19) L-menthol 0.02 (20) Isopropyl myristate 0.3 (21) Dimer two linoleic acid (phytosterol ester/isooctadecyl ester/hexadecyl ester/octadecyl ester/docosyl ester (Note 10) 0.2 (22) Sorbitan oleate 0.2 (23) Tocotrienols 0.02 (24) Carboxy vinyl polymer 0.02 (25) (Acrylic/alkyl acrylate (C10-30)) Cross-linked copolymer (Note 3) 0.02 (26) Xanthan gum 0.01 (27) Sodium hydroxide 0.01 (28) Hydrolyzed hyaluronic acid 0.01 (Note 10) PLANDOOL-S (manufactured by Nippon Seika Co., Ltd.)

(製造方法) A:將成分(1)~(14)以室溫均勻地混合。 B:將成分(15)~(23)以70℃均勻地溶解混合。 C:對前述A添加B並於70℃予以乳化。 D:將前述C冷卻至40℃後,添加成分(24)~(28)並予以均勻混合而得到美容液。 如以上所得之水中油乳化型美容液,其凝聚抑制效果、滲透感、無黏膩感、塗敷後肌膚之緊緻感優良。(Production method) A: The components (1) to (14) are uniformly mixed at room temperature. B: The components (15) to (23) are uniformly dissolved and mixed at 70°C. C: B is added to the aforementioned A and emulsified at 70°C. D: After cooling the aforementioned C to 40°C, the components (24) to (28) are added and uniformly mixed to obtain a beauty lotion. The oil-in-water emulsified beauty lotion obtained above has an anti-aggregation effect, a penetrating feel, a non-sticky feel, and an excellent firmness of the skin after application.

實施例15:防曬劑(水中油型) (成分)                                                  (%) (1)1,3-丁二醇                                         5.0 (2)二丙二醇                                           5.0 (3)山嵛基三甲基氯化銨                            0.1 (4)氫化卵磷脂 (註11)                              0.5 (5)膽固醇 (註12)                                    0.6 (6)植物固醇                                           0.1 (7)純水                                                 餘量 (8)菸鹼醯胺                                           3.0 (9)傳明酸                                              2.0 (10)(丙烯酸/丙烯酸烷基酯(C10-30))共聚物 (註13) 0.4 (11)三乙醇胺                                               0.4 (12)聚矽氧烷-15                                     1.2 (13)4-第三丁基-4’-甲氧基-二苯甲醯基甲烷   2.0 (14)對甲氧基肉桂酸2-乙基己酯                  7.0 (15)二乙胺基羥基苯甲醯基苯甲酸己酯        2.5 (16)硬脂酸硬化蓖麻油 (註14)                   1.0 (17)丙二醇二癸酸酯                                5.0 (18)油酸乙酯                                         0.3 (19)天然維生素E                                     0.1 (20)迷迭香油                                         0.01 (21)1,2-戊二醇                                       0.1 (22)氧化鋅                                            2.0 (23)水溶性膠原蛋白                                0.01 (24)德國洋甘菊花萃取物                          0.05 (25)金盞花萃取物                                   0.05 (26)甘油                                               1.0 (27)乙醇                                               7.0 (28)香料                                               0.1 (註11)NIKKOL RETINOL S-10(Nikko Chemicals公司製) (註12)海麗海洋膽固醇(日本水產公司製) (註13)Pemulen TR-2(NOVEON公司製) (註14)Castride MS(National Mimatsu公司製)Example 15: Sunscreen (oil-in-water type) (Element) (%) (1) 1,3-Butanediol 5.0 (2) Dipropylene glycol 5.0 (3)Behenyl trimethylammonium chloride 0.1 (4) Hydrogenated lecithin (Note 11) 0.5 (5) Cholesterol (Note 12) 0.6 (6) Plant sterols 0.1 (7) Pure water balance (8) Nicotine amine 3.0 (9) Chuanming acid 2.0 (10) (Acrylic acid/alkyl acrylate (C10-30)) copolymer (Note 13) 0.4 (11) Triethanolamine 0.4 (12) Polysiloxane-15 1.2 (13) 4-tertiary butyl-4'-methoxy-dibenzyl methane 2.0 (14) 2-ethylhexyl p-methoxycinnamic acid 7.0 (15) Diethylamino hydroxybenzyl hexyl benzoate 2.5 (16) Stearic acid hardened castor oil (Note 14) 1.0 (17) Propylene glycol dicaprate 5.0 (18) Ethyl oleate 0.3 (19) Natural Vitamin E 0.1 (20) Rosemary oil 0.01 (21) 1,2-pentanediol 0.1 (22) Zinc oxide 2.0 (23) Water-soluble collagen 0.01 (24) German chamomile flower extract 0.05 (25) Marigold extracts 0.05 (26) Glycerin 1.0 (27) Ethanol 7.0 (28) Spices 0.1 (Note 11) NIKKOL RETINOL S-10 (manufactured by Nikko Chemicals) (Note 12) Haili Marine Cholesterol (manufactured by Japan Fisheries Corporation) (Note 13) Pemulen TR-2 (manufactured by NOVEON) (Note 14) Castride MS (manufactured by National Mimatsu)

(製造方法) A:將成分(1)~(6)以75℃均勻地溶解混合。 B:將成分(7)~(11)以70℃均勻地溶解混合。 C:將成分(12)~(19)以80℃均勻地溶解混合。 D:對前述A添加B及C並於70℃予以乳化。 E:對前述D添加混合成分(20)~(28)後,冷卻至40℃而得到防曬劑(水中油型)。 如以上所得之防曬劑(水中油型),其凝聚抑制效果、滲透感、無黏膩感、塗敷後肌膚之緊緻感優良。(Production method) A: The components (1) to (6) are uniformly dissolved and mixed at 75°C. B: The components (7) to (11) are uniformly dissolved and mixed at 70°C. C: The components (12) to (19) are uniformly dissolved and mixed at 80°C. D: B and C are added to the aforementioned A and emulsified at 70°C. E: After adding the mixing components (20) to (28) to the aforementioned D, it is cooled to 40°C to obtain a sunscreen (oil-in-water type). The sunscreen (oil-in-water type) obtained above has an anti-aggregation effect, a penetrating feel, a non-sticky feel, and an excellent firmness of the skin after application.

實施例16:水中油型乳液 (成分)                                                 (%) (1)1,3-丁二醇                                        5.0 (2)二丙二醇                                                5.0 (3)氯化烷基三甲銨 (註2)                        0.03 (4)氫化大豆磷脂質 (註7)                        0.2 (5)膽固醇 (註12)                                   0.7 (6)純水                                                餘量 (7)菸鹼醯胺                                          8.0 (8)氫氧化鈉2%水溶液                             0.2 (9)N-肉豆蔻醯基-L-麩胺酸                       0.2 (10)聚氧乙烯(10)硬化蓖麻油                    0.2 (11)澳洲堅果油脂肪酸植物固醇酯 (註15)   1.0 (12)三(辛酸/辛酸)甘油酯                             0.2 (13)生育酚菸鹼酸酯                               0.01 (14)天然維生素E                                   0.1 (15)米胚芽油                                        0.01 (16)生育酚乙酸酯                                  0.01 (17)單油酸聚氧乙烯山梨醇酐(20E.O.)       1.5 (18)十八醇                                           0.5 (19)二十二醇                                        1.0 (20)1,2-戊二醇                                      0.1 (21)十八醇                                           0.5 (22)羧基乙烯聚合物                               0.2 (23)(丙烯酸鈉/丙烯醯基二甲基牛磺酸鈉)共聚物 (註16)                                           0.5 (24)傳明酸                                           1.0 (25)二甘油                                           0.5 (26)延命草萃取物                                  0.05 (27)鈍叉珊藻萃取物                               0.05 (28)黑大豆萃取物                                  0.05 (29)芝麻發芽物萃取物                            0.05 (30)甘油                                              1.0 (31)乙醇                                              5.0 (32)香料                                              0.1 (註15)PLANDOOL-MAS(日本精化公司製) (註16)SIMULGEL EG QD(SEPPIC公司製)Example 16: Oil-in-water emulsion (Element) (%) (1) 1,3-Butanediol 5.0 (2) Dipropylene glycol 5.0 (3) Alkyl trimethylammonium chloride (Note 2) 0.03 (4) Hydrogenated soybean phospholipids (Note 7) 0.2 (5) Cholesterol (Note 12) 0.7 (6) Pure water balance (7) Nicotine amine 8.0 (8) Sodium hydroxide 2% aqueous solution 0.2 (9) N-nutmegyl-L-glutamic acid 0.2 (10) Polyoxyethylene (10) Hardened castor oil 0.2 (11) Macadamia oil fatty acid plant sterol esters (Note 15) 1.0 (12) Three (caprylic acid/caprylic acid) glycerides 0.2 (13) Tocopherol nicotinic acid ester 0.01 (14) Natural Vitamin E 0.1 (15) Rice germ oil 0.01 (16) Tocopherol acetate 0.01 (17) Monooleic acid polyoxyethylene sorbitan (20E.O.) 1.5 (18) Stearyl alcohol 0.5 (19) Twentydiol 1.0 (20) 1,2-pentanediol 0.1 (21) Stearyl alcohol 0.5 (22) Carboxy vinyl polymer 0.2 (23) (Sodium Acrylate/Sodium Acrylate Dimethyl Taurate) Copolymer (Note 16) 0.5 (24) Chuan Ming acid 1.0 (25) Diglycerol 0.5 (26) Yemen grass extract 0.05 (27) Algae extracts 0.05 (28) Black soybean extract 0.05 (29) Sesame sprout extracts 0.05 (30) Glycerin 1.0 (31) Ethanol 5.0 (32) Spices 0.1 (Note 15) PLANDOOL-MAS (manufactured by Nippon Seika Co., Ltd.) (Note 16) SIMULGEL EG QD (manufactured by SEPPIC)

(製造方法) A:將成分(1)~(5)以75℃均勻地溶解混合。 B:一邊將前述A保持於75℃一邊添加一部分的成分(6),並以Disper mixer攪拌而得到囊泡分散液。 C:將其餘成分(6)~(8)以室溫均勻地溶解混合。 D:將成分(9)~(19)以80℃均勻地溶解混合。 E:一邊將前述D保持於75℃一邊添加經加熱之前述C而予以乳化。 F:對前述E添加混合成分(20)~(32)後,冷卻至40℃而得到水中油型乳液。 如以上所得之水中油型乳液,其凝聚抑制效果、滲透感、無黏膩感、塗敷後肌膚之緊緻感優良。(Production method) A: The components (1) to (5) are uniformly dissolved and mixed at 75°C. B: While maintaining the aforementioned A at 75°C, a part of the component (6) was added and stirred with a Disper mixer to obtain a vesicle dispersion. C: The remaining components (6) to (8) are uniformly dissolved and mixed at room temperature. D: The components (9) to (19) are uniformly dissolved and mixed at 80°C. E: The heated C is added while maintaining the D at 75°C to emulsify. F: After adding the mixing components (20) to (32) to the aforementioned E, it is cooled to 40°C to obtain an oil-in-water emulsion. The oil-in-water emulsion obtained above has excellent aggregation inhibition effect, penetrating feel, non-sticky feel, and excellent firmness of the skin after application.

Claims (7)

一種皮膚外用劑,其係含有下列成分(A)~(D): (A)菸鹼醯胺1~10質量%、 (B)陽離子性界面活性劑、 (C)陰離子性高分子、 (D)水。An external preparation for skin, which contains the following ingredients (A)~(D): (A) Nicotinamide 1-10% by mass, (B) Cationic surfactant, (C) Anionic polymer, (D) Water. 如請求項1之皮膚外用劑,其進一步含有成分(E)HLB為10~18的非離子性界面活性劑。Such as the skin external preparation of claim 1, which further contains a nonionic surfactant with a component (E) HLB of 10-18. 如請求項1或2之皮膚外用劑,其中前述成分(B)係含有選自二椰油醯乙基羥乙基甲基銨甲基硫酸鹽(dicocoylethyl hydroxyethylmonium methosulfate)及/或氯化烷基三甲銨的1種或2種以上。The external skin preparation of claim 1 or 2, wherein the aforementioned component (B) contains dicocoylethyl hydroxyethylmonium methosulfate and/or alkyl trimethyl chloride. One type or two or more types of ammonium. 如請求項1~3中任一項之皮膚外用劑,其中前述成分(C)係含有選自羧基乙烯聚合物及/或烷基改性羧基乙烯聚合物的1種或2種以上。The external preparation for skin according to any one of claims 1 to 3, wherein the aforementioned component (C) contains one or more selected from carboxyvinyl polymers and/or alkyl-modified carboxyvinyl polymers. 如請求項1~4中任一項之皮膚外用劑,其中前述成分(B)形成囊泡粒子。The external preparation for skin according to any one of claims 1 to 4, wherein the aforementioned component (B) forms vesicle particles. 一種抑制陽離子性界面活性劑及陰離子性高分子凝聚之方法,其特徵為在含有陽離子性界面活性劑、陰離子性高分子及水的皮膚外用劑中,將菸鹼醯胺添加至皮膚外用組成物中達1~10質量%的量。A method for inhibiting agglomeration of cationic surfactants and anionic polymers, which is characterized by adding nicotine amide to skin external preparations containing cationic surfactants, anionic polymers and water In the amount of 1-10% by mass. 一種提升皮膚外用劑的穩定化之方法,其特徵為在含有陽離子性界面活性劑、陰離子性高分子及水的皮膚外用劑中,將菸鹼醯胺添加至皮膚外用組成物中達1~10質量%的量。A method for improving the stabilization of external skin preparations, which is characterized by adding nicotine amide to skin external preparations up to 1-10 in skin external preparations containing cationic surfactants, anionic polymers and water The amount of mass%.
TW109135638A 2019-10-15 2020-10-15 External preparation for skin TW202128125A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-189014 2019-10-15
JP2019189014 2019-10-15

Publications (1)

Publication Number Publication Date
TW202128125A true TW202128125A (en) 2021-08-01

Family

ID=75538526

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109135638A TW202128125A (en) 2019-10-15 2020-10-15 External preparation for skin

Country Status (5)

Country Link
JP (1) JPWO2021075413A1 (en)
KR (1) KR20220082876A (en)
CN (1) CN114514012B (en)
TW (1) TW202128125A (en)
WO (1) WO2021075413A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022255271A1 (en) * 2021-06-04 2022-12-08 株式会社 資生堂 Cosmetic composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH101414A (en) 1996-06-12 1998-01-06 Kanebo Ltd Skin cosmetic
JP3922311B2 (en) 1996-10-29 2007-05-30 花王株式会社 Skin aging prevention cosmetics
CA2371920A1 (en) 1999-05-25 2000-11-30 The Procter & Gamble Company Niacinamide compositions with reduced tack
DE19961256A1 (en) * 1999-12-18 2001-06-21 Clariant Gmbh Cosmetic preparations
JP2004203803A (en) * 2002-12-26 2004-07-22 Sunstar Inc Cleanser composition
CN104837479B (en) * 2012-11-05 2018-01-09 株式会社高丝 Vesicle composition and the skin preparations for extenal use and cosmetics compounded with the vesicle composition
JP6715592B2 (en) 2014-12-08 2020-07-01 ワミレスコスメティックス株式会社 Cosmetics containing low molecular weight cationized hyaluronic acid
CN106806297A (en) * 2015-11-30 2017-06-09 朱延升 A kind of environmentally friendly oil resistant handguard film
CN106265392A (en) * 2016-11-07 2017-01-04 北京痘博士痤疮医学研究院 A kind of health skin purifies essence
CN106619149A (en) * 2017-01-23 2017-05-10 上海应用技术大学 Method for preparing nicotinamide-coated multivesicular liposomes
JP2019014709A (en) * 2017-07-07 2019-01-31 ポーラ化成工業株式会社 Skin care composition
JP6735426B2 (en) 2017-12-08 2020-08-05 ワミレスコスメティックス株式会社 Cationized vesicle and composition thereof
CN107823025A (en) * 2017-12-24 2018-03-23 姚佑灿 A kind of Whelk-eliminating paste
JP7356228B2 (en) * 2018-01-31 2023-10-04 株式会社コーセー Composition
CN109700754B (en) * 2019-02-27 2020-08-04 广东柏俐臣生物科技有限公司 Preparation method of face protection spray

Also Published As

Publication number Publication date
CN114514012B (en) 2024-06-14
KR20220082876A (en) 2022-06-17
JPWO2021075413A1 (en) 2021-04-22
WO2021075413A1 (en) 2021-04-22
CN114514012A (en) 2022-05-17

Similar Documents

Publication Publication Date Title
JP6904754B2 (en) Oil-in-water emulsified composition
JP2017178789A (en) Oil-in-water type emulsified composition
JP5550863B2 (en) Cosmetics
JP5832118B2 (en) Powder-containing cosmetic
JP2017088568A (en) Oil-in-water type emulsion cosmetic
JP6952402B2 (en) Cleansing cosmetics for the scalp
KR20150089517A (en) Transparency spray type Sun Screening Cosmetic composition by Inorganic UV Filter
TW202128125A (en) External preparation for skin
JP2009235010A (en) Skincare preparation for external use
JP6982697B2 (en) Composition for skin cosmetics
JP2018065799A (en) Cosmetic
CN111346028A (en) Multi-effect repairing anti-wrinkle composition, preparation method thereof and multi-effect repairing anti-wrinkle emulsion
JP2013189429A (en) Water-in-oil-in-water type emulsified cosmetic
KR20170112194A (en) Oil-In-Water Cosmetic Composition with Shape-Memory Ability
WO2019188119A1 (en) Hair cosmetic
WO2015111249A1 (en) Cleansing sheet
KR20140141431A (en) Hair treating agent
JP7256624B2 (en) Gel-form external preparation for skin or skin cosmetics
JP6266877B2 (en) Emulsion composition containing stearyl glycyrrhetinate
JP2017178835A (en) Alum-containing composition
JP2020105077A (en) Emulsion cosmetic
JP6005967B2 (en) UV protection cosmetics
JP2005179238A (en) Skin care preparation
JP6042628B2 (en) Oil-in-water emulsified cosmetic
JP4250501B2 (en) Gel oily cosmetic